Community post
jraverhoff
Chronic Myeloid Leukemia Discussion • August 4
MECOM Rearrangement
Has anyone seen data that suggest third generation TK Inhibitors have the same efficacy as second generation TK Inhibitors when treating CML with MECOM Rearrangement?
No comments yet.